David Thomas (L), VP of industry research and Emily Wheeler, director of infectious disease policy at BIO
Market issues prey on potential bounceback for antibiotics, says a new report — here's how to fix it
In the realm of drug R&D, the dramatic collapse of the antibiotics space — especially in light of the steady growth of antibiotic resistance — has been …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
